AI Article Synopsis

  • This study aims to assess how the combination of Lactobacillus acidophilus and montmorillonite powder affects inflammation in children with rotavirus enteritis (RVE).
  • A total of 94 children were divided into two groups, one receiving standard treatment plus montmorillonite and the other receiving standard treatment plus Lactobacillus for five days.
  • Results showed that the Lactobacillus group had a higher recovery rate, shorter symptom relief times, and lower inflammatory markers, though adverse reactions were similar in both groups.

Article Abstract

Objective: The aim of this study is to investigate the effects of the compound Lactobacillus acidophilus in combination with montmorillonite powder on the inflammatory response in children with rotavirus enteritis (RVE).

Methods: A total of 94 children with RVE admitted to our hospital between June 2021 and April 2023 were selected and divided into two groups using a random digit table method. Each group consisted of 47 children. Both groups were administered standard symptomatic treatment upon admission. The control group was additionally administered montmorillonite powder, while the observation group was administered compound L. acidophilus tablets in addition to the treatment administered to the control group. Both the treatments were administered for a duration of five days. Parameters such as clinical efficacy, symptom relief time (diarrhea, vomiting, fever, dehydration), inflammatory response (C-reactive protein (CRP)), and adverse reactions (constipation, bloating, drowsiness, skin allergy, dry mouth) were compared between the two groups.

Results: Post-treatment, the observation group exhibited a significantly higher total effective rate (95.74%) compared to the control group (78.72%). The symptom relief time for diarrhea ((2.23±0.48) days), vomiting ((1.38±0.25) days), fever ((1.91±0.68) days), and dehydration ((2.74±0.53) days) in the observation group were all significantly shorter than those in the control group ((3.42±0.71) days, (2.65±0.54) days, (2.76±0.84) days, and (4.60±0.89) days), respectively. The post-treatment CRP levels in the observation group were (5.26±1.32) mg/L, lower than those in the control group (7.45±1.58) mg/L, although this difference was not statistically significant. The incidence of adverse reactions was 14.89% in the observation group and 8.51% in the control group, with no significant difference between the groups.

Conclusion: The combination of compound L. acidophilus and montmorillonite effectively shortens the symptom recovery time and improves inflammatory response in children with RVE, while maintaining a high safety profile.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000542593DOI Listing

Publication Analysis

Top Keywords

control group
24
observation group
20
inflammatory response
16
montmorillonite powder
12
group
12
days
9
lactobacillus acidophilus
8
acidophilus montmorillonite
8
powder inflammatory
8
rotavirus enteritis
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!